Order Article Reprints

Iqbal H, Razzaq A, Uzair B, Ain NU, Sajjad S, Althobaiti NA, Albalawi AE, Menaa B, Haroon M, Khan M, et al. Correction: Iqbal et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials 2021, 14, 3155. Materials. 2026; 19(2):420. https://doi.org/10.3390/ma19020420

Iqbal, Haroon, Anam Razzaq, Bushra Uzair, Noor Ul Ain, Shamaila Sajjad, Norah Ayidh Althobaiti, Aishah Eid Albalawi, Bouzid Menaa, Muhammad Haroon, Muslim Khan, and et al. 2026. "Correction: Iqbal et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials 2021, 14, 3155" Materials 19, no. 2: 420. https://doi.org/10.3390/ma19020420

Iqbal, H., Razzaq, A., Uzair, B., Ain, N. U., Sajjad, S., Althobaiti, N. A., Albalawi, A. E., Menaa, B., Haroon, M., Khan, M., Khan, N. U., & Menaa, F. (2026). Correction: Iqbal et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials 2021, 14, 3155. Materials, 19(2), 420. https://doi.org/10.3390/ma19020420